VOR
Vor Biopharma (VOR) P/E Ratio
P/E Ratio as of Oct 27, 2026: -0.23
Average-0.2259
Median-0.2250
Minimum-0.2400
Maximum-0.2200
-0.23
0.01 (4.55%)past month
The P/E ratio for Vor Biopharma (VOR) is -0.23 as of Oct 27, 2026. This represents a increase of 187.50% compared to its 12-month average P/E ratio of -0.08. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Vor Biopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Vor Biopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vor Biopharma to industry peers.
Vor Biopharma P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Vor Biopharma’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Vor Biopharma to industry peers.
Vor Biopharma (VOR) P/E Ratio Insights
See Vor Biopharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Vor Biopharma (VOR)
Order type
Buy in
Order amount
Est. shares
0 shares
Vor Biopharma (VOR) P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| Oct 1, 2026 | $18.06 | -0.22 |
| Sep 1, 2026 | $22.64 | -0.27 |
| Aug 3, 2026 | $21.41 | -0.06 |
| Jul 1, 2026 | $18.39 | -0.06 |
| Jun 1, 2026 | $14.57 | -0.04 |
| May 1, 2026 | $13.85 | -0.04 |
| Apr 1, 2026 | $17.39 | -0.05 |
| Mar 2, 2026 | $15.90 | -0.04 |
| Feb 2, 2026 | $12.79 | -0.03 |
| Jan 2, 2026 | $11.64 | -0.03 |
Vor Biopharma (VOR) End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -0.23 | +666.67% |
| 2025 | -0.03 | -95.38% |
| 2024 | -0.65 | -45.83% |
| 2023 | -1.20 | -58.33% |
| 2022 | -2.88 | -52.94% |
| 2021 | -6.12 | — |
FAQs About Vor Biopharma (VOR) P/E ratio
The latest P/E ratio of Vor Biopharma (VOR) is -0.23, as of Oct 27, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Vor Biopharma’s last 12-month average P/E ratio is -0.08, compared to its current P/E ratio of -0.23. This reflects a increase of 187.50%.
Vor Biopharma’s current P/E ratio of -0.23 is higher than its last 12-month average P/E of -0.08. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Vor Biopharma’s average P/E ratio over the last 3 years is -0.45. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Vor Biopharma’s average P/E ratio over the last 5 years is -1.44. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.
Vor Biopharma (VOR) P/E Ratio Insights
See Vor Biopharma’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in Vor Biopharma (VOR)
Order type
Buy in
Order amount
Est. shares
0 shares
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.